Epsilon M&A Deal Report - Medipsy

Transaction Multiples for the Valuation of Private Companies

Ramsay Santé > Medipsy

Announced Date : 21 October 2013

Type : Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Ramsay Santé

Target: Medipsy

Target Country: France

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Medipsy SA operates hospitals and psychiatric clinics in France

No EMAT : 62131

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating **

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
28/11/2013 Private Group led by GIMV and UI Gestion Almaviva Sante France 0
12/10/2012 Private Group led by UI Gestion, Credit Agricole Regions Investissement and CDC Entreprises Domidep France 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database